Malaysia vs Rwanda: Antiretroviral therapy coverage for PMTCT
Malaysia
99.0%
in 2024
Rwanda
99.0%
in 2024
Malaysia rank
5th
Rwanda rank
5th
Antiretroviral therapy coverage for PMTCT over time
- Malaysia
- Rwanda
How they compare
Malaysia currently reports 99.0% against 99.0% in Rwanda, a difference of 0.0%.
The two have swapped places 7 times across 25 shared years of data; in 2000 it was Malaysia ahead.
Malaysia ranks 5th and Rwanda ranks 5th of 84 countries.
Across the 3 decades both report, Malaysia averaged higher in 2 and Rwanda in 1.
Head to head by decade
| Decade | Malaysia | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.7% | 35.0% | 51.7% | Malaysia |
| 2010s | 77.3% | 94.3% | 17.0% | Rwanda |
| 2020s | 98.0% | 97.2% | 0.8% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Malaysia or Rwanda?
- Malaysia, at 99.0% against 99.0% in Rwanda as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Malaysia and Rwanda?
- 0.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Rwanda?
- 25 years are reported by both, from 2000 to 2024.
- How do Malaysia and Rwanda rank globally for antiretroviral therapy coverage for pmtct?
- Malaysia ranks 5th and Rwanda ranks 5th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).